Skip to content

Clinical trials

Phase 2 Major Depressive Disorder trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Phase: Phase 2 Status: Unknown status Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20071
20151
20162
20171
20182
20193
20202
20213
20222
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.2
Shanghai Mental Health Center2
The University of New South Wales2
Axsome Therapeutics, Inc.1
CCTU-Core1
Centre Hospitalier Universitaire de Besancon1
Chase Therapeutics Corporation1
Hanyang University Seoul Hospital1
Jiangsu Hansoh Pharmaceutical Co., Ltd.1
King's College London1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder21
Depressive Disorder, Treatment-Resistant2
Mood Disorders2
Alcoholism1
Anxiety Disorders1
Bipolar Disorder1
Depressive Disorder1
Dysthymic Disorder1
Inflammation1
Neoplasms1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.